172 related articles for article (PubMed ID: 36333819)
21. A ten-year retrospective study on livedo vasculopathy in Asian patients.
Gan EY; Tang MB; Tan SH; Chua SH; Tan AW
Ann Acad Med Singap; 2012 Sep; 41(9):400-6. PubMed ID: 23052434
[TBL] [Abstract][Full Text] [Related]
22. [Vasculitis and vasculopathy].
Marković A
Acta Med Croatica; 2012 Oct; 66 Suppl 1():19-24. PubMed ID: 23193816
[TBL] [Abstract][Full Text] [Related]
23. [Livedoid vasculopathy. Pathogenesis, diagnosis and treatment of cutaneous infarction].
Goerge T
Hautarzt; 2011 Aug; 62(8):627-34; quiz 635. PubMed ID: 21786003
[TBL] [Abstract][Full Text] [Related]
24. Livedoid vasculopathy - current aspects of diagnosis and treatment of cutaneous infarction.
Kerk N; Goerge T
J Dtsch Dermatol Ges; 2013 May; 11(5):407-10. PubMed ID: 23437985
[TBL] [Abstract][Full Text] [Related]
25. Livedoid vasculopathy: Clinical course and long-term outcome in Asian patients with a review of the literature.
Rujitharanawong C; Chularojanamontri L; Trakanwittayarak S; Pinkaew S; Nuttawong S
Dermatol Ther; 2021 Jan; 34(1):e14569. PubMed ID: 33219608
[TBL] [Abstract][Full Text] [Related]
26. Efficacy of new low-dose oral anticoagulants in recalcitrant livedoid vasculopathy.
Furukawa F; Mizawa M; Makino T; Shimizu T
BMJ Case Rep; 2017 Jul; 2017():. PubMed ID: 28739563
[TBL] [Abstract][Full Text] [Related]
27. A comprehensive review on pathogenesis, associations, clinical findings, and treatment of livedoid vasculopathy.
Seguí M; Llamas-Velasco M
Front Med (Lausanne); 2022; 9():993515. PubMed ID: 36569162
[TBL] [Abstract][Full Text] [Related]
28. Pain Management Options in a Patient with Livedoid Vasculopathy and Peripheral Neuropathy.
Palanisamy N; Chinnappan J; Bachuwa G
Eur J Case Rep Intern Med; 2023; 10(1):003727. PubMed ID: 36819654
[TBL] [Abstract][Full Text] [Related]
29. Livedoid vasculopathy: thrombotic or inflammatory disease?
Khenifer S; Thomas L; Balme B; Dalle S
Clin Exp Dermatol; 2010 Oct; 35(7):693-8. PubMed ID: 19874344
[TBL] [Abstract][Full Text] [Related]
30. Prevention of recurrent ulceration of livedoid vasculopathy with long-term apixaban monotherapy.
Osada SI; Ishikawa N; Hasunuma N; Manabe M
J Dermatol; 2019 Apr; 46(4):e142-e143. PubMed ID: 30156315
[No Abstract] [Full Text] [Related]
31. Intravenous immunoglobulins in difficult-to-treat ulcerated livedoid vasculopathy: five cases and a literature review.
Bounfour T; Bouaziz JD; Bézier M; Petit A; Viguier M; Rybojad M; Bagot M
Int J Dermatol; 2013 Sep; 52(9):1135-9. PubMed ID: 23488633
[TBL] [Abstract][Full Text] [Related]
32. What caused this painful skin erosion? Livedoid vasculopathy.
Monroe JR
JAAPA; 2012 May; 25(5):20. PubMed ID: 22712143
[No Abstract] [Full Text] [Related]
33. Livedoid vasculopathy: review of pathogenesis, clinical presentation, diagnostic workup, and treatment.
Haunson GT; Judy DW; Prall NC; Miller RA
Cutis; 2012 Dec; 90(6):302-6. PubMed ID: 23409480
[TBL] [Abstract][Full Text] [Related]
34. Intravenous immunoglobulin in resistant livedoid vasculopathy: Analysis of a case series.
Ozden MG; Ozdemir H; Şenturk N
Dermatol Ther; 2020 Mar; 33(2):e13229. PubMed ID: 31965687
[TBL] [Abstract][Full Text] [Related]
35. The management of livedoid vasculopathy focused on direct oral anticoagulants (DOACs): four case reports successfully treated with rivaroxaban.
Franco Marques G; Criado PR; Alves Batista Morita TC; Cajas García MS
Int J Dermatol; 2018 Jun; 57(6):732-741. PubMed ID: 29663354
[TBL] [Abstract][Full Text] [Related]
36. Lymphocytic vasculitis in livedoid vasculopathy: A report of 137 cases.
Yuan Y; Liu Y; Ban F; Sun Z; Liao W; Wang L
J Cutan Pathol; 2024 Feb; 51(2):155-162. PubMed ID: 37837185
[TBL] [Abstract][Full Text] [Related]
37. Livedoid vasculopathy - a challenging disease.
Vieira R; Bernardes JM; Pinto JA; Costa L
Acta Reumatol Port; 2016; 41(3):273-274. PubMed ID: 27155327
[TBL] [Abstract][Full Text] [Related]
38. [Livedoid vasculopathy secondary to coeliac disease].
Henry J; Brault F; Brouillard C; Baudin M; Gervaise A; Pouaha J; Cuny JF; Valois A
Ann Dermatol Venereol; 2017 May; 144(5):374-377. PubMed ID: 28283193
[TBL] [Abstract][Full Text] [Related]
39. Livedoid vasculopathy: an in-depth analysis using a modified Delphi approach.
Alavi A; Hafner J; Dutz JP; Mayer D; Sibbald RG; Criado PR; Senet P; Callen JP; Phillips TJ; Romanelli M; Kirsner RS
J Am Acad Dermatol; 2013 Dec; 69(6):1033-1042.e1. PubMed ID: 24028907
[TBL] [Abstract][Full Text] [Related]
40. Livedoid vasculopathy as a coagulation disorder.
Criado PR; Rivitti EA; Sotto MN; de Carvalho JF
Autoimmun Rev; 2011 Apr; 10(6):353-60. PubMed ID: 21184847
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
